Cerity Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
31,836
-494
-2% -$15.3K ﹤0.01% 1792
2025
Q4
$905K Buy
32,330
+16,562
+105% +$496K ﹤0.01% 1760
2025
Q3
$473K Sell
15,768
-4,242
-21% -$120K ﹤0.01% 2010
2025
Q2
$572K Sell
20,010
-6,230
-24% -$185K ﹤0.01% 1798
2025
Q1
$866K Buy
26,240
+8,310
+46% +$271K ﹤0.01% 1494
2024
Q4
$511K Buy
17,930
+2,234
+14% +$64.2K ﹤0.01% 1748
2024
Q3
$439K Buy
+15,696
New +$418K ﹤0.01% 1842
2024
Q2
Sell
-23,960
Closed -$649K 2231
2024
Q1
$649K Buy
+23,960
New +$680K ﹤0.01% 1476

Other funds holding ALKS

Cerity Partners's ALKS Position: Q1 2026 in Review

Cerity Partners reduced its Alkermes (ALKS) stake by 1.5% in Q1 2026, selling an estimated $15.3K and leaving 31,836 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Cerity Partners first reported a position in ALKS in Q1 2024 and has held it in 8 quarters since. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Cerity Partners held 31,836 shares of Alkermes worth $1.13M as of Q1 2026.
  • Cerity Partners sold 494 Alkermes shares in Q1 2026, an estimated $15.3K.
  • Alkermes made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1792 holding.
  • Cerity Partners first reported a position in Alkermes in Q1 2024 and has held it in 8 quarters since.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.